Jeon et al. conducted a screening of FDA approved drugs in Vero cells to discover promising antiviral drug candidates against SARS‐CoV‐2 infection. 240  They reported 24 drugs that exhibited antiviral efficacy with IC50 values between 0.1 and 10 µM.